- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Follicular Non-Hodgkin´s Lymphoma
Total 5333 results
-
Weill Medical College of Cornell UniversityGilead SciencesTerminatedFollicular LymphomaUnited States
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineTerminatedFollicular LymphomaUnited States
-
Sunnybrook Health Sciences CentreCompletedFollicular LymphomaCanada
-
Fondazione Italiana Linfomi ONLUSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteCompleted
-
Hoffmann-La RocheCompleted
-
St. Louis UniversityCompletedFollicular LymphomaUnited States
-
Charite University, Berlin, GermanyUnknownFollicular Lymphoma
-
Fondazione Italiana Linfomi ONLUSUnknown
-
Lymphoma Study AssociationJanssen-Cilag International NVTerminatedFollicular LymphomaFrance, Belgium
-
Narendranath EpperlaWithdrawnRecurrent Marginal Zone Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Nodal Marginal Zone Lymphoma | Recurrent Nodal Marginal Zone Lymphoma | Recurrent Splenic Marginal Zone Lymphoma | Refractory Splenic Marginal Zone Lymphoma and other conditions
-
Nathan DenlingerBristol-Myers SquibbRecruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | Diffuse Large B-Cell Lymphoma-Recurrent | Follicular Lymphoma-Recurrent | High Grade B-Cell Lymphoma-Recurrent | Primary Mediastinal Large B-Cell Lymphoma-Recurrent | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Recurrent and other conditionsUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterNot yet recruitingHIV Infection | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedIbrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell TransplantRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Recurrent Follicular Lymphoma | Refractory Follicular...United States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Follicular LymphomaUnited States, Spain, United Kingdom, Italy, France, Japan, Germany
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownRelapsed / Refractory Follicular LymphomaChina
-
Azienda Ospedaliera Città della Salute e della...UnknownGrade 3b Follicular Lymphoma
-
Columbia UniversityCelgeneTerminatedLymphoma | Hodgkin Lymphoma | Lymphoid Malignancies | Non-hodgkin LymphomaUnited States
-
Hoffmann-La RocheCompletedFollicular Lymphoma | Chronic Lymphocytic LeukemiaKorea, Republic of
-
National Cancer Institute (NCI)RecruitingRecurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Regeneron PharmaceuticalsCompletedRelapsed/Refractory Follicular LymphomaAustria, France, Germany, United Kingdom
-
Hoffmann-La RocheCompletedAdvanced Follicular LymphomaGermany, Brazil, United Kingdom, Spain, Japan, United States, Netherlands
-
The Lymphoma Academic Research OrganisationEpizyme, Inc.Active, not recruitingLymphoma | Follicular Lymphoma | DLBCLFrance, Belgium
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingFollicular Lymphoma | Splenic Marginal Zone Lymphoma | Mantle Cell Lymphoma | Indolent Non-hodgkin Lymphoma | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Nodal Marginal Zone LymphomaUnited States
-
Joseph TuscanoNational Cancer Institute (NCI); Seagen Inc.RecruitingBrentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular LymphomaRecurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
National Cancer Institute (NCI)Not yet recruitingClassic Follicular Lymphoma | Follicular Lymphoma With Unusual Cytological Features
-
Genentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaUnited States, France, Canada, Netherlands
-
Joseph TuscanoNational Cancer Institute (NCI); CelgeneActive, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingRefractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditionsUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationNot yet recruitingRelapsed or Refractory Follicular Lymphoma
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Follicular LymphomaUnited States, Korea, Republic of, Taiwan, China, Spain, United Kingdom, Australia, France, Germany, Japan, Turkey, Brazil, Poland, Ukraine, Italy, Russian Federation
-
Joseph TuscanoNational Cancer Institute (NCI); Genentech, Inc.; Pharmacyclics LLC.RecruitingAnn Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Emory UniversityMillennium Pharmaceuticals, Inc.CompletedLymphoma, B-Cell | Follicular LymphomaUnited States
-
Jonathan FriedbergNational Cancer Institute (NCI); National Institutes of Health (NIH)Active, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Mucosal-Associated Lymphoid Tissue LymphomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedFollicular Lymphomas | CD19+ Diffuse Large B-cell Lymphomas | Mantle Cell LymphomasUnited States
-
SecuraBioTerminatedLymphoma | Lymphoma, Non-Hodgkin | Follicular Lymphoma | Chronic Lymphocytic Leukemia | Lymphoma, Small LymphocyticUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Richter Syndrome | Refractory Transformed Non-Hodgkin Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Marker Therapeutics, Inc.RecruitingHodgkin Lymphoma | Non Hodgkin Lymphoma | Hodgkin Lymphoma, Adult | Non-Hodgkin Lymphoma, Adult | Non-Hodgkin Lymphoma, Refractory | Non-Hodgkin Lymphoma, Relapsed | Hodgkin's Lymphoma, Relapsed, AdultUnited States
-
Kami MaddocksNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent... and other conditionsUnited States
-
Centre Leon BerardTerminated
-
oubai, MD/PhDRecruitingDiffuse Large B Cell Lymphoma | Follicular Lymphoma Grade 3BChina
-
Weill Medical College of Cornell UniversityMemorial Sloan Kettering Cancer CenterTerminatedFollicular Lymphoma | Mantle Cell LymphomaUnited States
-
St. Jude Children's Research HospitalParexel; Jazz PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Non Hodgkins LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular... and other conditionsUnited States
-
University Health Network, TorontoCompletedHodgkin's Lymphoma | Non Hodgkin's LymphomaCanada
-
Zhejiang DTRM BiopharmaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Richter's Transformation | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedLymphoma, Follicular | Lymphoma, Non-Hodgkin | Leukemia | Hodgkin Lymphoma | Multiple Myleoma | Lympocytic, FollicularChina, Hong Kong, Taiwan
-
Precision BioSciences, Inc.CompletedLymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B-cell Non Hodgkin Lymphoma | Leukemia, Lymphocytic, Chronic | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Novartis PharmaceuticalsCompletedFollicular Lymphoma, Mantle Cell LymphomaAustria, France, United States, Germany